Greg Roumeliotis

Greg Roumeliotis has an extensive background in business development within the biotech and healthcare industries. Greg currently serves as the Vice President of Global Business Development at Orgenesis Inc., a company focused on cell and gene therapy biotech. Prior to this, Greg held similar roles at Breakthrough Genomics and Veritas Genetics. Greg has also worked in various senior business development positions at companies such as Innovative Life Sciences Ltd and Cryo-Save Group. With a Master of Science degree in Health Care Policy & Management from the University of Birmingham, Greg Roumeliotis brings a wealth of knowledge and experience to the biotech industry.